Specialties

Thoracic oncology; Translational medicine

Clinical Interests

She is a medical oncologist and physician-scientist specializing in lung cancers and the development of precision medicine including molecular-targeted therapy and immunotherapy. She works along with a team of experts including surgeons, radiation oncologists, pathologists, and nurses. Her team strives to not only provide personalized anti-tumor therapies but also manage drug-related side effects for patients with lung cancer. Her main research interests focus on precision therapy based on molecular and genetic alterations in lung cancer including EGFR, HER2 variations and new drug development. She has participated in numerous pivotal clinical trials in lung cancer and acted as Principal Investigator in 8 clinical trials.

Biography

She has been working at Guangdong Provincial People's Hospital since 2000. From 2000 to 2013, she worked in Respiratory Medicine Department. Since 2013, She has been working in Division 4 of Pulmonary Oncology in Guangdong Lung Cancer Institute.

Education

Doctor of Medicine (Oncology), Southern Medical University

Master of Internal Medicine, School of Medicine, Wuhan University

Bachelor of Medicine, Tongji Medical University

Visiting investigator at Memorial Sloan Kettering Cancer Center, New York, USA from 2019 to 2020.

Awards and Honors

Awarded "Role Model" and "Outstanding Contribution Award" in the fight against SARS in 2003.

Professional memberships

Deputy chairman of the Lung Cancer Committee of the Guangdong Medical Women's Association

Committee of the Guangdong Society of Translational Medicine

Member of International Association for the Study of Lung Cancer (IASLC)

Member of Chinese Society of Clinical Oncology (CSCO)

Publications

Published more than 30 SCI research papers in the past, including 8 papers as first-author or co-first author, and one of them was published in Annal Oncology (IF=18.274).